Thermo Fisher (TMO) on Wednesday beat Wall Street estimates for second-quarter profit and revenue, helped by steady demand for its products and services used for developing therapies.
Thermo Fisher Beats Quarterly Estimates
About the Author: ryounglao
Leave A Comment